TherapeuticsMD was founded in 2008 and is headquartered in Boca Raton, US

Chief Executive Officer

Chief Financial Officer

President

Chief Product Officer

MD, Chief Medical Officer

Chief Strategy Performance Officer

TherapeuticsMD has an office in Boca Raton

Boca Raton, US (HQ)

6800 Broken Sound Pkwy Nw

TherapeuticsMD's revenue was reported to be $4 m in Q1, 2017

USD

## Revenue (Q1, 2017) | 4 m |

## Gross profit (Q1, 2017) | 3.3 m |

## Gross profit margin (Q1, 2017), % | 83% |

## Net income (Q1, 2017) | (21.2 m) |

## EBIT (Q1, 2017) | (21.3 m) |

## Market capitalization (25-Jul-2017) | 1.1 b |

## Cash (31-Mar-2017) | 113.5 m |

TherapeuticsMD's current market capitalization is $1.1 b.

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Revenue | 8.8 m | 15 m | 20.1 m | 19.4 m |

## Revenue growth, % | 71% | 34% | (4%) | |

## Cost of goods sold | 2 m | 3.7 m | 4.5 m | 4.2 m |

## Gross profit | 6.8 m | 11.4 m | 15.6 m | 15.2 m |

## Gross profit Margin, % | 78% | 76% | 78% | 78% |

## R&D expense | 53.9 m | |||

## Operating expense total | 32.6 m | 65.4 m | 100.8 m | 105.4 m |

## EBIT | (25.8 m) | (54 m) | (85.2 m) | (90.3 m) |

## EBIT margin, % | (294%) | (360%) | (423%) | (466%) |

## Interest expense | 1.2 m | 1.2 m | ||

## Interest income | 27.2 k | 37.3 k | 17.4 k | |

## Pre tax profit | (85.1 m) | (89.9 m) | ||

## Net Income | (28.4 m) | (54.2 m) | (85.1 m) | (89.9 m) |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 3.8 m | 4.2 m | 4.5 m | 4.8 m | 5.2 m | 4.9 m | 4.4 m | 5.5 m | 4 m |

## Cost of goods sold | 893 k | 1.1 m | 1 m | 1 m | 1.2 m | 1.1 m | 1.1 m | 1.2 m | 659.6 k |

## Gross profit | 2.9 m | 3.1 m | 3.4 m | 3.8 m | 4 m | 3.8 m | 3.3 m | 4.3 m | 3.3 m |

## Gross profit Margin, % | 76% | 74% | 77% | 79% | 77% | 78% | 74% | 78% | 83% |

## R&D expense | 8.2 m | 14.9 m | 18.2 m | 24.2 m | 16.4 m | 15.1 m | 13.8 m | 14.7 m | 7.7 m |

## Operating expense total | 8.2 m | 14.9 m | 18.2 m | 24.2 m | 16.4 m | 15.1 m | 13.8 m | 14.7 m | 7.7 m |

## EBIT | (10.9 m) | (17.8 m) | (20.9 m) | (27.3 m) | (19.5 m) | (21 m) | (21.2 m) | (25.1 m) | (21.3 m) |

## EBIT margin, % | (291%) | (426%) | (468%) | (562%) | (376%) | (425%) | (482%) | (454%) | (534%) |

## Interest income | 9.2 k | 9.4 k | 9.8 k | 2.6 k | 2.8 k | 41.6 k | |||

## Pre tax profit | (19.5 m) | (20.9 m) | (21.2 m) | ||||||

## Net Income | (10.9 m) | (17.8 m) | (20.9 m) | (48.1 m) | (67.6 m) | (20.9 m) | (42 m) | (67 m) | (21.2 m) |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Cash | 54.2 m | 51.4 m | 64.7 m | 131.5 m |

## Inventories | 1 m | 1.2 m | 690.2 k | 1.1 m |

## Current Assets | 59.4 m | 56.2 m | 70.7 m | 139.4 m |

## Total Assets | 62 m | 59.1 m | 73.7 m | 142.5 m |

## Accounts Payable | 2.1 m | 6.3 m | 3.1 m | 7.4 m |

## Current Liabilities | 7.3 m | 10.7 m | 10.7 m | 15 m |

## Additional Paid-in Capital | 135.1 m | 183 m | 282.7 m | 437 m |

## Retained Earnings | (80.5 m) | (134.7 m) | (219.8 m) | (309.7 m) |

## Total Equity | 54.7 m | 48.4 m | 63.1 m | 127.5 m |

## Financial Leverage | 1.1 x | 1.2 x | 1.2 x | 1.1 x |

USD | Q2, 2014^{} | Q3, 2014^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|

## Cash | 35.6 m | 67 m | 67.2 m | 81.1 m | 182.1 m | 166.5 m | 147.5 m | 113.5 m |

## Inventories | 1.5 m | 1 m | 1.2 m | 870.1 k | 957.4 k | 883.7 k | 843.4 k | 1.3 m |

## Current Assets | 41.8 m | 72.2 m | 73 m | 87.8 m | 189.8 m | 174 m | 156.1 m | 121.3 m |

## Total Assets | 44.4 m | 74.6 m | 75.7 m | 90.5 m | 193 m | 176.6 m | 158.8 m | 124.4 m |

## Accounts Payable | 2.3 m | 5.6 m | 5.8 m | 5.3 m | 3.4 m | 3 m | 4.2 m | 6.1 m |

## Current Liabilities | 6.9 m | 11 m | 11.7 m | 11.7 m | 9.6 m | 9.3 m | 12.5 m | 14.1 m |

## Additional Paid-in Capital | 138 m | 181.9 m | 245.7 m | 279.7 m | 423.9 m | 428.9 m | 433 m | 441 m |

## Retained Earnings | (100.6 m) | (118.4 m) | (182.9 m) | (202.3 m) | (240.8 m) | (261.9 m) | (286.9 m) | (330.9 m) |

## Total Equity | 37.5 m | 63.6 m | 63 m | 77.6 m | 183.4 m | 167.2 m | 146.4 m | 110.3 m |

## Financial Leverage | 1.2 x | 1.2 x | 1.2 x | 1.2 x | 1.1 x | 1.1 x | 1.1 x | 1.1 x |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Net Income | (28.4 m) | (54.2 m) | (85.1 m) | (89.9 m) |

## Depreciation and Amortization | 58.1 k | 52.5 k | 62.4 k | 132.5 k |

## Accounts Receivable | (1.1 m) | (458 k) | (917.7 k) | (4 m) |

## Inventories | 571.6 k | (138.5 k) | 492 k | (386.2 k) |

## Accounts Payable | 472.9 k | 4.2 m | (3.2 m) | 4.2 m |

## Cash From Operating Activities | 52.6 m | (2.8 m) | 13.3 m | (69.1 m) |

## Purchases of PP&E | (40.8 k) | (31 k) | (165.3 k) | (396.2 k) |

## Cash From Investing Activities | (583.6 k) | (606.8 k) | (584.4 k) | (1.3 m) |

## Cash From Financing Activities | 137.2 m | |||

## Interest Paid | 212.9 k | 212.9 k | 212.9 k |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (10.9 m) | (17.8 m) | (20.9 m) | (48.1 m) | (67.6 m) | (20.9 m) | (42 m) | (67 m) | (21.2 m) |

## Depreciation and Amortization | 14.1 k | 12.7 k | 13.6 k | 27.9 k | 44.4 k | 19.6 k | 24.3 k | 40.5 k | 49.7 k |

## Accounts Receivable | (502.8 k) | (1.2 m) | (1.5 m) | (2.3 m) | (1.9 m) | (4.2 m) | 580.9 k | ||

## Inventories | 1.5 m | 1 m | 222.9 k | (66.6 k) | 312.1 k | (267.3 k) | (193.5 k) | (153.2 k) | (262.3 k) |

## Accounts Payable | 2.3 m | 5.6 m | (91.9 k) | (508.5 k) | (1 m) | 304.5 k | (86.8 k) | 1.1 m | (1.2 m) |

## Cash From Operating Activities | (34.7 m) | (53.5 m) | (20.5 m) | ||||||

## Purchases of PP&E | (15.6 k) | (15.6 k) | (74.5 k) | (265 k) | (307.7 k) | (27.8 k) | |||

## Cash From Investing Activities | (36.9 k) | (94.4 k) | (133.6 k) | (165 k) | (663.1 k) | (863.4 k) | (135.3 k) | ||

## Cash From Financing Activities | 137.2 m | 137.2 m | 2.7 m |

USD | Y, 2017 |
---|---|

## Revenue/Employee | 25.1 k |

## Financial Leverage | 1.1 x |